NCT03657290View on ClinicalTrials.gov

A Study in Evaluating Bioequivalence of Test and Reference Vadadustat 450 MG and 150 MG Tablets and to Determine Food Effect on the 450 MG Tablet

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

August 3, 2018

Primary Completion Date

October 16, 2018

Study Completion Date

October 16, 2018

Conditions
Healthy
Interventions
DRUG

vadadustat

Vadadustat Tablets

Trial Locations (1)

21225

Paraxel International, Baltimore

Sponsors
All Listed Sponsors
lead

Akebia Therapeutics

INDUSTRY

NCT03657290 - A Study in Evaluating Bioequivalence of Test and Reference Vadadustat 450 MG and 150 MG Tablets and to Determine Food Effect on the 450 MG Tablet | Biotech Hunter | Biotech Hunter